Business Software & Services Market Worth $650.13 Billion By 2025

The global business software and services market size is expected to reach USD 650.13 billion by 2025, registering a CAGR of 10.7% from 2019 to 2025, according to a new report by Grand View Research, Inc. Increasing volume of business data and automation of business processes across various industries such as healthcare, retail, and manufacturing are expected to drive the growth.

Numerous factors such as timely product delivery, reduced production costs, and improved operational efficiency delivered by effective business software and services are expected to propel the market growth over the forecast period. Business software and services are extensively used in business processes as they help reduce operational costs.

Enterprises are widely adopting cloud-based deployment solutions owing to technological developments and growing focus on offering flexibility and mobility to users. This is prompting vendors to develop software solutions that can be deployed through cloud platforms.

Technological innovation, growing use of new data sources, and penetration of cloud-based services are further driving the need for customized software solutions for specific business operations. Increasing demand for optimized delivery mechanisms, initiating from point of production to the point of consumption, is encouraging enterprises to adopt supply chain management business software.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/business-software-services-market

Further key findings from the report suggest:

Sales and marketing segment is anticipated to expand at the highest CAGR of 11.2% from 2019 to 2025. The software is widely used by businesses to combine their sales procedures and tasks
Managed services segment is anticipated to register the highest CAGR of 12.2% from 2019 to 2025 owing to the increasing dependence of enterprises on IT assets to improve their productivity
Cloud segment is expected to emerge as the fastest-growing deployment segment over the next six years as this mode of deployment eliminates the need to regularly, manually upgrade business software solutions and enables users to access data from any location in a hassle-free way
Small and Medium Enterprises (SME) segment is expected to expand at the highest CAGR of above 11.2% over the forecast period. The growing number of government initiatives through digital SME campaigns such as video marketing, social media, and search engine marketing are expected to drive the growth
Healthcare is expected to emerge as the fastest-growing end use segment over the next six years, attributed to increasing demand for streamline the documentation, exchange of health data, and its storage
North American accounted for the largest market share in terms of revenue and is expected to continue to dominate the market over the forecast period. Increased adoption of advanced technologies such as hybrid architecture, JavaScript, machine learning, artificial intelligence, and blockchain are contributing significantly to the regional growth
The key players in the business software and services market include Acumatica, Inc.; Deltek, Inc.; Epicor Software Corporation; IBM Corporation; Infor Inc.; NetSuite Inc.; Microsoft Corporation; SAP SE; Oracle Corporation; Totvs SA; Unit4; and SYSPRO

Automotive Electric Fuel Pumps Market Worth $18.44 Billion By 2025

The global automotive electric fuel pumps market size is estimated to reach a value of USD 18.44 billion by 2025, progressing at a CAGR of 5.0% from 2019 to 2025, according to a new study by Grand View Research, Inc. An automotive electric fuel pump is used to pump fuel from tanks to injectors, which further sprays fuel into engine with high pressure. Surging demand for high fuel-efficient pumps to reduce the overall fuel consumption in vehicles along with rise in global vehicle production and sales is anticipated to propel the market over the forecast period.

An electric fuel pump is widely used in vehicles, owing to its numerous benefits such as high product reliability, power output, and fuel efficiency as compared to mechanical fuel pumps. The adoption of automotive electric fuel pumps among original equipment manufacturers (OEMs) in modern vehicles has increased significantly as the product ensures accurate injection pressure and flow of fuel to engine. Moreover, stringent government regulations to produce fuel-efficient and low carbon emission vehicles are expected to create remarkable growth opportunities for the market during the forecast period.

Prominent market players such as Robert Bosch GmbH, Denso Corporation, Delphi Automotive, and Continental AG are increasingly focusing on partnership agreements with automobile manufacturers to supply electric fuel pumps to enhance their overall market presence and profitability. Besides, a few key market players are expanding their production facilities in developing countries to avail the product at affordable costs to OEMs and aftermarket consumers. For instance, in 2013, Continental AG started its new production plants for fuel pumps in India to supply the products to its key clients such as Volkswagen Group.

Despite numerous product benefits, increasing production of counterfeit products, coupled with rapidly growing adoption of electric vehicles, is likely to hinder the growth of the automotive electric fuel pumps market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-electric-fuel-pumps-market

Further key findings from the report suggest:

The passenger car segment is poised to dominate the market in terms of revenue throughout the forecast period. Increasing personnel mobility requirements and soaring need for fuel efficient passenger vehicles can contribute to the growth of the segment
Turbine style electric fuel pumps held the leading revenue share in the market in 2018 as they offer higher operational efficiency, lower noise emission, and can deliver accurate pressure measure, driving higher performance of vehicles
Macroeconomic condition and regulation such as mining ban in India may affect the demand of heavy commercial vehicles (HCVs). Increasing demand for LCVs, particularly in rural areas, is anticipated to unfold new growth opportunities for the segment
The Asia Pacific automotive electric fuel pumps market is estimated to experience the highest growth in terms of value during the forecast period. Rising demand for passenger vehicles in developing countries such as India, China, and Korea is escalating the growth of the segment
According to Valeo Group, the number of vehicles produced in China has doubled since 2007, with more than 23 million vehicle productions in 2014, which accounted for 27.0% of the global production
The key industry participants include Denso Corporation, Delphi Automotive PLC, Continental AG, General Motors Company, Pricol Limited, and Robert Bosch. Other prominent vendors include Visteon Corporation, Federal-Mogul Corporation, Daewha Fuel Pump Ind., Ltd., and ACDelco.

Trauma & Extremities Device Market Size Worth $17.9 Billion By 2026

The global trauma and extremities devices market size is expected to reach USD 17.9 billion by 2026, according to a new report by Grand View Research Inc. It is anticipated to expand at a CAGR of 7.7% during the forecast period. Rising geriatric population along with the prevalence of target diseases such as osteoporosis is anticipated to propel the growth. Introduction of new technologies in terms of material and technique and the non-invasive nature of the employed material is augmenting the demand. In July 2016, DePuy Synthes launched a new hand locking system used for deformities and fracture fixation. This device is designed to reduce soft tissue irritation and facilitate healing.

Moreover, companies are investing in new product development, which is anticipated to aid the market growth. In 2015, Smith & Nephew invested USD 222 million on research and development, yielding a promising product pipeline for 2016. It has already launched a new product, SUTUREFIX, a suture anchor in February 2015. The product is expected to improve hip and shoulder repair by providing additional fixation points.

The trauma and extremities device market is led by few players, while local implant manufacturers share the remaining market. DePuy Synthes, Stryker, Zimmer Biomet, and Medtronic and others are key players while Advanced Orthopedic Solutions, Emerge Medical, and Bioretec Ltd. are the emerging players in this vertical.

In 2018, internal fixation led the market owing to the advantages associated with the devices such as sorter hospital stay, lesser scars, and skin pressure, early functionality achieved in patients, and lesser risk of nonunion and malunion of bones. Industry players are adding new products with better functionality, which replicate the native anatomy, enhancing both, functionality and durability. In July 2016, the Acumed’s wrist fixation implants, Acu-Loc and Acu-Loc 2, reached a worldwide sales milestone of 0.5 million in 2 years. This indicates the high demand for internal fixation devices, which is expected to witness growth over the forecasted period.

Amongst internal fixation methods, plates and screws are the most popular owing to the less blood loss involved and shorter operative time. This segment is expected to witness growth owing to the focus of companies on integrating different tools into one system. For instance, in July 2016, DePuy launched its locking hand system comprising 40 basic and specific plates for different cases of hand fractures. This aids the surgeons in adjusting the insertion specific to the patient’s bone anatomy to provide more stability.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/trauma-extremities-market

Further Key Findings from the Report Suggest:

Internal fixation dominated the trauma and extremities device market in 2018 due to the advantages associated with these devices such as lesser scars and reduced hospital stay, and lesser risk of nonunion and malunion of bones
In 2018, North America held the leading market share of more than 45%. The Affordable Care Act includes a separate grant for trauma care. Though this fund was discontinued in 2006, it was reauthorized in 2014 and set to an annual USD 12 million. The fund allocation aimed at improving trauma care centers in terms of access and quality, especially in the rural areas
Some of the key players are DePuy Synthes, Stryker, Zimmer Biomet, Smith & Nephew, Wright Medical Group N.V., Advanced Orthopedic Solutions, Integra Lifesciences, Acumed, Bioretec Ltd., Cardinal Health. They focus on growth strategies such as launch of new products, partnerships, new approval, and mergers & acquisitions

Durable Medical Equipment Market Size Worth $271.0 Billion By 2026

The global durable medical equipment (DME) market size is expected to reach USD 271.0 billion by 2026 registering a CAGR of 6.1%, according to a new report by Grand View Research, Inc. The market is primarily driven by rise in chronic diseases, such as kidney failures and cancer. Moreover, technological advancements along with strong reimbursement scenario will boost the DME market further. For instance, in January 2019, WHILL, Inc., a U.S.-based personal electric vehicle, introduced new technology WHILL autonomous drive at the Consumer Electronic Sow held at the Las Vegas. In the past, Medicare has taken steps to bring reimbursement of DME products in line with other payers.

In this direction, in December 2015, the Center for Medicare & Medicare Services (CMS) issued a new rule of prior authorization process for DME, Prosthetics, Orthotics, and Supplies (DMEPOS). The DMEPOS includes the master list of 135 items, which require prior authorization before beneficiary receives an item. In addition, growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and lack of skilled professionals may limit the durable medical equipment market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/durable-medical-equipment-dme-market

Further key findings from the study suggest:

Personal mobility devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability
Nursing homes is anticipated to be the fastest-growing segment over the study period as these facilities offer custodial care like skilled care, such as bathing and dressing
Europe led the market with the largest share in 2018 and will witness a steady growth in future on account of the presence of major companies in the region
Asia Pacific is expected to register the highest CAGR from 2019 to 2026 owing to the presence of a large target population base and improving healthcare facilities
Some of the key companies in the global DME market are Invacare Corporation; ArjoHuntleigh; Stryker Corporation; Hill Rom, Inc.; Drive Medical; GF Health Products, Inc.; Sunrise Medical; Medline Industries, Inc.; and Carex Health Brands, Inc.

Surgical Stapling Devices Market Size Worth $8.02 Billion By 2026

The global surgical stapling devices market size is anticipated to reach USD 8.02 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.23% during the forecast period. Application of surgical staplers has gradually evolved from invasive surgeries to minimally invasive surgeries. With introduction of advanced surgical staplers, difficulties associated with the use of conventional staplers have been addressed.

Obesity is increasing among adults as well as adolescents below 18 years of age due to sedentary lifestyles and unhealthy diet patterns in this age group. In case of eating habits, people are more inclined towards fast food rather than healthy food. Growing busy schedule and increasing stress are both causing people to consume packed and processed food.

Severe cases of obesity cause other conditions, such as diabetes and cardiovascular conditions, resulting in many opting for bariatric surgery. According to the Canadian Institute for Health Information (CIHI) 2014 data, the number of bariatric surgeries has drastically increased from 1,600 in 2006-2007 to 6,000 in 2012-2013. This indicates high demand for these surgeries owing to increasing awareness about surgical options for weight loss.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-stapling-market

Further key findings from the report suggest:

Manual surgical stapling devices dominated the market in terms of revenue in 2018. However, powered devices are projected to witness strong growth during the forecast period
An alarming number of emergency cases can lead to surgical fatigue, thereby, reducing productivity. Powered stapling devices allow surgeons to perform more number of surgeries in emergency wards
There is an increasing demand for disposable devices due to heightened concerns for communicable infections. Owing to which, disposable staplers are likely to dominate the market through 2025
Disposable staples are made of plastic, whereas reusable staples are made of stainless steel. Both disposable and reusable staples have disposable cartridges and although reusable, staplers generate lesser surgical waste
North America dominated the overall market in terms of revenue in 2018. The growth of the region can be attributed to surging bariatric surgeries, introduction of powered staples, and soaring need for tissue and wound management
Key industry contributors include Covidien plc; Ethicon Endo-Surgery, Inc.; Intuitive Surgical, Inc.; United States Surgical Corp; Cardica, Inc.; Zimmer Holdings, Inc.; Stryker Corporation; Smith & Nephew plc; Conmed Corporation; and CareFusion Corporation
In November 2018, Ethicon launched ECHELON FLEX GST System for exceptional staple line integrity across wide range of tissue thickness under its Bariatric Revision Surgical Solutions.

In vivo CRO Market Size Worth $5.81 Billion By 2026

The global in vivo cro market is anticipated to reach USD 5.81 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the

Click the link below:
https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market

Further key findings from the report suggest:

Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Anti-infective Agents Market Worth $144.8 Billion By 2026

The global anti-infective agents market size is expected to reach over USD 144.8 billion by 2026 according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 3.4% during the forecast period. Rising prevalence of infectious diseases such as HIV, H1N1, and Ebola virus reflect the profound changes in behavioral patterns of communities over the recent decades. The societal changes and increasing awareness among healthcare professionals and patients are driving the growth.

Organizations, such as the World Health Organization (WHO) and Centers for Disease control and Prevention (CDC) are actively involved in spreading awareness amongst people regarding the fatal implications of infectious diseases and the importance of early treatment. The CDC has collaborated with the National Health Ministry (NHM) in an attempt to spread awareness and to enhance the treatment of communicable diseases in developing countries such as Brazil, China, Nigeria, and India.

However, introduction of novel therapeutics with increased potency and efficacy and the commercialization of pipeline products, such as commercialization of Omadacycline in 2018 for the treatment of Community Acquired Bacterial Pneumonia (CABP), are expected to propel the growth of the anti-infective agents market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/anti-infective-agents-market

Further key findings from the report suggest:

Antiviral was estimated to be the largest segment with a market share of 48.8% in 2018 owing to the high price associated with the new potent anti-viral drugs, such as Vicriviroc for the treatment of HIV
Antibacterial segment is anticipated to register the fastest CAGR of 4.0% during the forecast period, as antibacterial is the first line of treatment for a large range of infections. Increased prescription and accessibility of antibacterial due to their over-the-counter status is anticipated to further drive the segment
Development of combination drugs to treat and prevent serious and life-threatening infections is expected to propel the usage of anti-infective drugs. For instance, in 2012, Gilead Sciences, Inc. launched Stribild, a comprehensive treatment regimen inclusive of four drugs (cobicistat, elvitegravir, emtricitabine, and tenofovir disoproxil fumarate) used for the treatment of HIV patients without prior retroviral treatment record
Oral route of administration was estimated to be the largest segment in 2018 owing to new product development and presence of strong product pipeline
Hospital pharmacy led the anti-infective agents market in 2018 while e-commerce is expected to be the fastest growing segment during the forecast period
North America was one of the leading regions in terms of revenue in 2018. High prevalence of infectious diseases including hospital-acquired infections in both, children and adults, and the resultant overuse of antibiotics coupled with increased accessibility of non-prescription anti-infectives are the major drivers
Asia Pacific is one of the fastest growing regional segments owing to the presence of high, unmet demand for novel drugs, rapid improvements in healthcare infrastructure coupled with rising awareness among healthcare professionals and patients
Some of the major companies operating in this market are Abbott; Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Bayer AG; AstraZeneca; Boehringer Ingelheim; and Novartis AG.
Effective disease management involves a range of long-term strategies such as new product development, mergers and acquisitions, co-development, and business expansions. For instance, in 2015, ReViral received funding of USD 21 million for the development of its RV521 drug by the Wellcome Trust.

Nerve Repair And Regeneration Market Worth $17.8 Billion By 2026

The global nerve repair and regeneration market size is expected to reach USD 17.8 billion by 2026 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. Demand for neurological disorder therapies owing to increasing incidence and rising awareness about the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are also projected to help boost the market growth.

In January 2016, the EU Horizon 2020 program funded a research project ‘Autostem’, launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects of new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market growth. In July 2018, the Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).

In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.

Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM’s portfolio is complementary to Stryker’s Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U.S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/nerve-repair-regeneration-market

Further key findings from the study suggest:

In 2018, neuromodulation and neurostimulation devices segment led the market due to increased cases of Central Nervous System (CNS) disorders and awareness about mental disorders and available treatments
Biomaterials is anticipated to expand at the fastest CAGR during the forecast period due to technological advancements and development of biodegradable polymers that can help enhance spinal stabilization, healing of fractures, and reduce hospitalization
North America led the market in 2018 owing to technological advancements and advent of new devices. Government initiatives and funding and increased cases of injured CNS, such as injuries to the spinal cord and brain, were some of the major reasons responsible for the region’s growth
Asia Pacific is expected to be the fastest-growing market during the forecast period. Growing geriatric population, technological advancements, and many unmet medical needs are some of the factors driving the region’s growth
In February 2016, Indian scientists working for Revita Life Sciences were approved to conduct clinical trials in 20 clinically dead patients to bring specific parts of their CNS back to life
Combination of therapies including cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells and other techniques that were successful in bringing patients out of coma were to be used
Existing medical devices were combined with regenerative biological medicines with an objective to achieve such a complex initiative
Some of the key companies include Boston Scientific, Inc.; Stryker Corporation; St. Jude Medical, Inc.; Medtronic plc.; Baxter International, Inc.; AxoGen, Inc.; Polyganics B.V.; Integra; Cyberonics, Inc.; and Lifesciences Corporation

Flow Chemistry Market Size Worth $2.39 Billion By 2025

The global flow chemistry market size is projected to be valued at USD 2.39 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 10.0% during the forecast period. Lower operating costs of the technology coupled with eco-friendliness is projected to boost the growth.

Substantial reduction in waste generation along with elimination of non-renewable production methods are priorities from a global environment standpoint. Major economies are therefore introducing regulations with a view to minimize the damage to the environment. Numerous governments are introducing measures to achieve the targets set by the Paris Agreement under the United Nations Framework Convention on Climate Changes (UNFCCC), specifically to mitigate the emission of greenhouse gases.

Continuous Stirred Tank (CST) and Plug Flow (PF) are the most commonly adopted reactors in the flow chemistry market. CST reactor systems require limited human intervention to function thereby incurring low labor costs associated with its adoption. Additionally, both reactor technologies have a high output rate, resulting in low production costs.

Increasing adoption of microreactors in specialty chemical, fine chemical, and pharmaceutical manufacturing sectors has contributed substantially to controlling environment damage along with saving manufacturing costs. In the bulk chemicals manufacturing industry, microreactors are used to manufacture styrene, formaldehyde, Ethylene Oxide (EO), and Vinyl Acetate Monomer (VAM) among others.

Pharmaceutical industry is expected to witness maximum growth over the forecast period owing to the ease of continuous separation and crystallization technique offered by flow chemistry technology. Growing need for production cost control coupled with increasing competition in the Active Pharmaceutical Ingredients (API) manufacturing industry is projected to contribute significantly to the demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/flow-chemistry-market

Further key findings from the report suggest:

Academia and research application held a market share of 12.45% in 2018 owing to growing use of renewable technologies for manufacturing along with affordable cost of flow chemistry
Asia Pacific is expected to witness the highest CAGR of 11.3% owing to growing adoption of affordable, energy saving, renewable technologies along with substantial investment from petrochemical industry
Microreactor is expected to register an astounding CAGR of 21.0% over the forecast period, due to the demand from pharmaceutical manufacturers owing to better selectivity, affordable production costs, and low waste generation by the product
Notable players operating in the flow chemistry market include Am Technology, CEM Corp., Biotage AB, Syrris Ltd, and Vapourtec Ltd. among others. Companies are strategizing to enhance their geographic presence by making in-roads in Asia Pacific, which is expected to have substantial potential.

Metallic Stearate Market Worth $4.84 Billion by 2025

The global metallic stearate market is expected to reach USD 4.84 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.5% during the forecast period. Growing rubber and plastics industry is projected to drive the product demand.

Thermoplastics such as polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyethylene terephthalate, expanded polystyrene, ABS, SAN, polyamides, fluoropolymer, and polycarbonate were the key contributors to the market growth. Primary applications of plastics include films, sheet, plates, boxes, strip, foil, and bottles. Packaging, building and construction, automotive, electronic, electrical, and consumer goods are the leading end-user industries that consume plastics. As a result, the prolific increase in plastics and plastic-based articles production is anticipated to drive the metallic stearate market over the forecast period.

The strong presence of automotive manufactures in China, Japan, and South Korea has boosted the demand for synthetic rubber. China and South East Asian countries appeared to be the major producers of synthetic rubber. Prospective growth in the automotive industry has propelled the demand for rubber in tire applications. A sizeable increase in rubber production is anticipated to fuel the demand for metallic stearates over the next few years.

Technological advancements are likely to continue driving the market growth. Various types of techniques are used in metallic stearate production. Nanofilms of metallic stearates can be produced using Langmuir−Blodgett (LB) techniques. The films are characterized by X-Ray Diffraction technique. The conductive properties of films are altered with environmental conditions; as a result, they can be used as a humidity sensor

Rising health concerns, altering demographics and lifestyles, favorable research studies, and innovative production techniques are the factors projected to drive the market. Investments and business expansions made by market participants to meet the increasing product demand in Asia Pacific and North America are projected to offer substantial growth opportunities over the next few years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/metallic-stearate-market

Further key findings from the report suggest:

In terms of revenue, the zinc product is expected to expand at a CAGR of 5.5% over the forecast period
Plastics led the application segment with a market share of over 30% in 2018
Increasing purchasing power parity and demand for cosmetics is projected to drive the metallic stearate market over the forecast period
Some of the key participants are Dover Chemical Corporation, Valtris Specialty Chemicals, Peter Greven GmbH & Co. KG, Baerlocher GmbH, Faci S.p.A, and Norac Additives.